Cargando…
Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection
Patients infected with SARS‐CoV‐2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1–8 months after mild COVID‐19. All patients received immunosuppressive therapy and improved gradually wi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539072/ https://www.ncbi.nlm.nih.gov/pubmed/35996829 http://dx.doi.org/10.1002/ehf2.14088 |
_version_ | 1784803428513349632 |
---|---|
author | Bollano, Entela Polte, Christian Lars Mäyränpää, Mikko I. Oldfors, Anders Bergh, Niklas Lehtonen, Jukka Kandolin, Riina |
author_facet | Bollano, Entela Polte, Christian Lars Mäyränpää, Mikko I. Oldfors, Anders Bergh, Niklas Lehtonen, Jukka Kandolin, Riina |
author_sort | Bollano, Entela |
collection | PubMed |
description | Patients infected with SARS‐CoV‐2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1–8 months after mild COVID‐19. All patients received immunosuppressive therapy and improved gradually within the following months. The possible temporal association between the CS/GCM and COVID‐19 infection might suggest that COVID‐19 could be a trigger for granulomatous myocarditis. |
format | Online Article Text |
id | pubmed-9539072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95390722022-10-11 Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection Bollano, Entela Polte, Christian Lars Mäyränpää, Mikko I. Oldfors, Anders Bergh, Niklas Lehtonen, Jukka Kandolin, Riina ESC Heart Fail Case Reports Patients infected with SARS‐CoV‐2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1–8 months after mild COVID‐19. All patients received immunosuppressive therapy and improved gradually within the following months. The possible temporal association between the CS/GCM and COVID‐19 infection might suggest that COVID‐19 could be a trigger for granulomatous myocarditis. John Wiley and Sons Inc. 2022-08-22 /pmc/articles/PMC9539072/ /pubmed/35996829 http://dx.doi.org/10.1002/ehf2.14088 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Bollano, Entela Polte, Christian Lars Mäyränpää, Mikko I. Oldfors, Anders Bergh, Niklas Lehtonen, Jukka Kandolin, Riina Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection |
title | Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection |
title_full | Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection |
title_fullStr | Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection |
title_full_unstemmed | Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection |
title_short | Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection |
title_sort | cardiac sarcoidosis and giant cell myocarditis after covid‐19 infection |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539072/ https://www.ncbi.nlm.nih.gov/pubmed/35996829 http://dx.doi.org/10.1002/ehf2.14088 |
work_keys_str_mv | AT bollanoentela cardiacsarcoidosisandgiantcellmyocarditisaftercovid19infection AT poltechristianlars cardiacsarcoidosisandgiantcellmyocarditisaftercovid19infection AT mayranpaamikkoi cardiacsarcoidosisandgiantcellmyocarditisaftercovid19infection AT oldforsanders cardiacsarcoidosisandgiantcellmyocarditisaftercovid19infection AT berghniklas cardiacsarcoidosisandgiantcellmyocarditisaftercovid19infection AT lehtonenjukka cardiacsarcoidosisandgiantcellmyocarditisaftercovid19infection AT kandolinriina cardiacsarcoidosisandgiantcellmyocarditisaftercovid19infection |